Vitiligo researchVitiligo Scientific Study 28 October 2022 Translational Research in Vitiligo Erica L. Katz and John E. Harris Vitiligo is a… VIPOC 0 Love0
Events 27 September 2022 Paul Monteiro presentation at EADV The EADV (European Academy for Dermatology and Venereology) held… VIPOC 0 Love0
VitiligoVitiligo research 21 September 2022 5 Facts You Didn’t Know About Vitiligo When cells that make pigment (color) in the skin are… VIPOC 0 Love0
Events 13 September 2022 VIPOC Presidential Dinner 2022 The VIPOC presidential Dinner was a great success. It was… VIPOC 0 Love0
Covid and vaccinationVitiligo Scientific Study 13 September 2022 COVID‐19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine by Irene López Riquelme, 1 María Dolores Fernández Ballesteros, 1 Ana Serrano Ordoñez, 1 and Daniel Jesús… VIPOC 0 Love0
Vitiligo researchVitiligo Scientific Study 27 July 2022 FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura) The JAK inhibitor cream is the first medication that can restore pigment in people with this autoimmune disease. By Becky Upham July 22, 2022 On July 18, the… VIPOC 0 Love0
News 9 June 2022 3RD VIPOC CONFERENCE 21ST-23RD APRIL 2022 AMSTERDAM (THE NETHERLANDS) 50 attendees - 20 nations 20 leaders of vitiligo organizations… VIPOC 0 Love0
VitiligoVitiligo researchvitiligo treatment 4 May 2022 Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study Part 2 Separated, n (%) 4 (12.9) 4(13.8) 0 Number of siblings… VIPOC 0 Love0
VitiligoVitiligo researchVitiligo Scientific Studyvitiligo treatment 12 April 2022 Factors affecting quality of life in patients with vitiligo Part 2 Patients and methods Participants and settings A nationwide questionnaire-based study… VIPOC 0 Love0
the upside of skin conditionVitiligoVitiligo stories 1 April 2022 Painful process and rebirth of turning ‘white’ Seeing the upside of skin condition, vitiligo STRUGGLE: Moleboheng Molebatsi,… VIPOC 0 Love0